Posted: December 11, 2019
Alice Shaw, MD, has joined Novartis as the vice president, global head of Translational Clinical Oncology. Previously, Dr. Shaw was the director of Thoracic Oncology and the Paula O’Keeffe Endowed Chair in Thoracic Oncology at Massachusetts General Hospital, as well as a professor of medicine at Harvard Medical School. Dr. Shaw’s research in ALK and ROS1 rearrangements in NSCLC and in targeted-therapy resistance has led to novel treatment strategies. ✦
